Determination of the aldosterone/renin ratio in 269 patients with adrenal incidentaloma

Experimental and Clinical Endocrinology and Diabetes

Volumn 115, Issue 8, 2007, Pages 518-521

  Vierhapper, H ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Adrenal; Aldosterone; Renin

Indexed keywords

ALDOSTERONE; ANTIHYPERTENSIVE AGENT; RENIN;

ADRENAL DISEASE; ADRENAL INCIDENTALOMA; ALDOSTERONE BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERCORTISOLISM; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PHEOCHROMOCYTOMA; PLASMA RENIN ACTIVITY; PREVALENCE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL;

ADENOMA; ADRENAL GLAND NEOPLASMS; ADULT; AGED; ALDOSTERONE; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; INCIDENTAL FINDINGS; MALE; MIDDLE AGED; REFERENCE VALUES; RENIN;

EID: 35848938711     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-973058     Document Type: Article

References (19)

1. Ross NS, Aron DC. Hormonal evaluation of the patient with an incidentally discovered adrenal mass. N Engl J Med 1990; 323: 1402-1405
2. Rosen HN, Swartz SL. Subtle glucocorticoid excess in patients with adrenal incidentaloma. Am J Med 1992; 92: 213-216
3. Gross MD, Shapiro B. Clinical review 50: clinically silent adrenal masses. J Clin Endocrinol Metab 1993; 77: 885-888
4. Hiramatsu K, Yamada T, Yukimura Y, Komiya I, Ichikawa K, Ishihara M, Nagata H, Izumiyama T. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients. Arch Intern Med 1981; 141: 1589-1593
5. Loh KC, Koay ES, Khwa MC, Emmanuel SC, Young WF. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab. 2000; 85: 2854-2859
6. Bravo EL, Tarazi RC, Dustan HP, Fouad FM, Textor C, Gifford RW, Vidt DG. The changing clinical spectrum of primary aldosteronism. Am J Med 1983; 74: 641-651
7. Streeten DHP, Tomycz N, Anderson Jr GH. Reliability of screening methods for the diagnosis of primary aldosteronism. Am J Med 1979; 67: 403-413
8. Weinberger MH, Grim CE, Hollifield JW, Kem DC, Ganguly A, Kramer NJ, Yune HY, Wellman H, Donahue JP. Primary aldosteronism: diagnosis, localization, and treatment. Ann Intern Med 1979; 90: 386-395
9. McKenna TJ, Sequeira SJ, Heffernan A, Chambers J, Cunningham S. Diagnosis under random conditions of all disorders of the renin-angiotensin- aldosterone axis, including primary hyperaldosteronism. J Clin Endocrinol Metab 1991; 73: 952-957
10. Montori VM, Young WF. Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism - A systematic review of the literature. Endorcinol Metab Clin N Amer 2002; 31: 619-632
11. Lim PO, Cardale K, Watson AD, MacDonnell TM. Potentially high prevalence of primary aldosteronism in a primary-care population. Lancet 1999; 353: 40
12. Fardella CE, Mosso L, Gomezsanchez C, Cortes P, Soto J, Gomez L, Pinto M, Huete A, Oestreicher E, Foradori A, Mantero J. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 2000; 85: 1863-1867
13. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomezsanchez CE, Veglio F, Young WF. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 2004; 89: 1045-1050
14. Giacchetti G, Ronconi V, Lucarelli G, Boscaro M, Mantero F. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol. J Hypertens 2006; 24: 737-745
15. Bernini G, Moretti A, Argenio G, Salvetti A. Primary aldosteronism in normokalemic patients with adrenal incidentalomas. Eur J Endocrinology 2002; 146: 523-529
16. Zipser RD, Speckart PF. 'Normotensive' primary aldosteronism. Ann Intern Med 1978; 88: 655-666
17. Kono T, Ikeda F, Oseko F, Imura H, Tanimura H. Normotensice primary aldosteronism: Report of a case. J Clin Endocrinol Metab 1981; 52: 1009-1013
18. Gessl A, Vierhapper H. Development of hypertension in a patient with initially normotensive primary aldosteronism. Abstracts, 84th Annual Meeting of the Endocrine Society, San Francisco, June 19-21, 2002;P3-463.y
19. Kaplan NM. Cautions over the current epidemic of primary aldosteronism. Lancet 2001; 357: 953-954